Genetics/B-ORG Institute/I-ORG Inc./I-ORG ,/O Cambridge/B-GPE ,/O Mass./B-GPE ,/O said/O it/O was/O awarded/O U.S./B-GPE patents/O for/O Interleukin/O -/O 3/O and/O bone/O morphogenetic/O protein/O ./O
The/O patent/O for/O Interleukin/O -/O 3/O covers/O materials/O and/O methods/O used/O to/O make/O the/O human/O blood/O cell/O growth/O factor/O via/O recombinant/O DNA/O technology/O ./O
Sandoz/B-ORG Ltd./I-ORG has/O licensed/O certain/O manufacturing/O and/O marketing/O rights/O for/O Interleukin/O -/O 3/O from/O Genetics/B-ORG Institute/I-ORG and/O is/O conducting/O preclinical/O studies/O with/O it/O ./O
Interleukin/O -/O 3/O may/O help/O in/O treating/O blood/O cell/O deficiencies/O associated/O with/O cancer/O treatment/O ,/O bone/O marrow/O transplants/O and/O other/O blood/O -/O cell/O disorders/O ,/O Genetics/B-ORG Institute/I-ORG said/O ./O
The/O second/O patent/O describes/O bone/O morphogenetic/O protein/O -/O 1/O ,/O a/O substance/O that/O can/O induce/O formation/O of/O new/O cartilage/O ./O
The/O patent/O covers/O BMP/O -/O 1/O type/O proteins/O and/O pharmaceutical/O compositions/O and/O methods/O for/O treating/O bone/O or/O cartilage/O defects/O ,/O Genetics/B-ORG Institute/I-ORG said/O ./O
The/O company/O added/O that/O it/O has/O filed/O patent/O applications/O ``/O on/O a/O large/O number/O of/O different/O BMP/O proteins/O ''/O and/O the/O patent/O on/O BMP/O -/O 1/O is/O the/O first/O it/O has/O received/O ./O
BMP/O products/O may/O be/O useful/O in/O fracture/O healing/O and/O in/O treating/O bone/O loss/O associated/O with/O periodontal/O disease/O and/O certain/O cancers/O ,/O the/O company/O said/O ./O
